US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist

6.230
-0.070-1.11%

Close Dec 12 16:00 ET

527.46MMarket Cap-2.53P/E (TTM)

Verve Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Verve Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 3.173M	--
--	2024/Q4	-- / 4.238M	--
--	2024/Q3	6.865M / 3.256M	--
Aug 8, 2024	2024/Q2	6.692M / 2.711M	--
--	2024/Q1	5.695M / 2.250M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 3.173M--

--2024/Q4-- / 4.238M--

--2024/Q36.865M / 3.256M--

Aug 8, 20242024/Q26.692M / 2.711M--

--2024/Q15.695M / 2.250M--

Unlock Free Earnings Estimates

Open Account

Verve Therapeutics Earnings Reports

Verve Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5 07:31 ET

Verve Therapeutics | 8-K: Verve Therapeutics Announces Pipeline Progress and Reports Third Quarter 2024 Financial Results

Nov 5 07:16 ET

Verve Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 07:34 ET

Verve Therapeutics | 8-K: Verve Therapeutics Announces Pipeline Progress and Reports Second Quarter 2024 Financial Results

Aug 8 07:19 ET

Analyst Rating

Updated: Dec 10, 2024

Strong Buy

Buy
83.33%
Hold
16.67%
Sell
0.00%

Price Target

No Data

Heat List

Overall